The medical device industry is changing rapidly, with innovations in minimally invasive treatments, advanced biomaterials, and patient-focused care leading the way. In this evolving environment, the interventional device contract development and manufacturing organization (CDMO) market is playing an increasingly vital role. Below, we explore top device trends and discuss how CDMOs are helping original equipment manufacturers (OEMs) bring new products to life.
The Growing Interventional CDMO Market
Market Size and Growth
The global medical device outsourcing market—which includes interventional device segments—was valued at around $110–120 billion in 2022 and is growing at a compound annual growth rate (CAGR) of roughly 10–12%. CDMOs offer technical expertise and streamlined processes, making them valuable partners for OEMs in both early-stage product development and large-scale manufacturing.
Key Markey Dynamics
- Specialized Expertise: OEMs often turn to CDMOs with specific capabilities in catheter design, stent manufacturing, and implant assembly.
- Regulatory Know-How: Established CDMOs maintain rigorous quality systems and regulatory compliance, which can shorten development timelines.
- Resource Management: Outsourcing development and manufacturing tasks lets OEMs focus more on commercialization.
- Faster Iterations: CDMOs with integrated supply chains and rapid prototyping capabilities can get products to market more quickly.
Major Device Trends in 2025
Structural Heart & Endovascular Therapies
- Market Growth: The structural heart device market may reach about $15.8 billion by 2025, growing at a CAGR of around 10%.
- Notable Developments: Transcatheter aortic and mitral valve replacements, as well as devices for aortic aneurysm repairs, highlight the push for minimally invasive cardiac solutions.
- CDMO Tie-In: By leveraging advanced catheter and implant production methods, CDMOs can help OEMs quickly iterate and scale these life-saving products.
Neurovascular & Peripheral Vascular Devices
- Market Growth: Neurovascular device sales are expected to top $4 billion in 2025. Peripheral vascular grafts and dialysis access technologies are also in high demand as chronic conditions become more common.
- Notable Developments: Flow diverters for stroke prevention, stent retrievers for acute ischemic stroke, and next-generation grafts for dialysis patients.
- CDMO Tie-In: The small, intricate components in neurovascular devices require tight tolerances—an area where CDMOs with specialized tooling and manufacturing expertise can excel.
Bioabsorbable & Advanced Material Applications
- Market Growth: Bioabsorbable implants are projected to hit nearly $1 billion in 2025, growing at about a 7% CAGR.
- Notable Developments: Bioabsorbable stents and tissue fixation devices reduce the need for permanent implants and associated long-term risks.
- CDMO Tie-In: Unique polymer extrusion, molding, and assembly skills are critical for producing these cutting-edge devices.
Robotic Assisted, Navigation-Enabled Catheters
- Market Growth: Surgical robotics could reach $11.8 billion by 2025, with an 11%+ CAGR. Advanced catheters with built-in navigation features are also on the rise.
- Notable Developments: Robotics-assisted bronchoscopy platforms and EP (electrophysiology) mapping catheters for cardiac ablation.
- CDMO Tie-In: Collaborating with a CDMO that has experience in electronics integration, robotic assembly, and sophisticated handle design can speed product development.
Remote Monitoring & Implantable Sensors
- Market Growth: Remote monitoring devices are forecast to surpass $23 billion by 2025, at a CAGR of around 12%.
- Notable Developments: Heart failure monitoring devices, continuous glucose monitors, and insulin delivery pumps.
- CDMO Tie-In: High-quality assembly, electronics integration, and reliable sealing techniques are essential for implantable sensors.
Oncology Therapies
- Market Growth: The oncology device segment may exceed $120 billion by 2025, growing at about 10% annually.
- Notable Developments: Catheter-based delivery for chemotherapy, brachytherapy seed placement, and specialized stent designs for tumor management.
- CDMO Tie-In: Prototyping and quick design adjustments are key when developing interventional oncology products that require precise targeting.
Gastrointestinal Solutions
- Market Growth: Global GI devices are projected to reach $50 billion by 2025, at around 6% CAGR.
- Notable Developments: Endoluminal bariatric procedures, advanced meshes for hernia repair, and flexible endoscopic tools.
- CDMO Tie-In: Flexible material handling and robust testing protocols help ensure patient safety and consistent performance in GI applications.
Interventional Pediatric Devices
- Market Growth: The pediatric interventional device market, though smaller in scale than adult segments, is estimated to grow steadily—some estimates place annual growth at 7–9% through 2025. This includes pediatric cardiac devices, catheters, and specialized implants that accommodate smaller anatomies.
- Notable Developments: Pediatric transcatheter heart valves, growth-accommodating stents, and specialized feeding or drainage catheters tailored to infants and young children. These devices often require unique designs to address rapid growth and varied physiology.
- CDMO Tie-In: Designing for pediatric populations calls for precision miniaturization, biocompatibility, and careful consideration of developmental changes. CDMOs equipped with advanced manufacturing techniques, thorough testing protocols, and a strong understanding of regulatory requirements can help OEMs develop these highly specialized devices.
The interventional medical device sector is undergoing significant growth across multiple therapy areas—from heart valves and neurovascular implants to advanced robotics, remote monitoring solutions, and pediatric applications. As a result, OEMs are increasingly turning to CDMOs for specialized expertise, faster product development, and reliable manufacturing scale-up. By maintaining strong quality systems and technical capabilities, interventional CDMOs play a pivotal role in bringing next-generation medical devices—adult and pediatric alike—to market swiftly and effectively.